Love hormone put to the test as painkiller
NCT ID NCT07053774
First seen Jun 25, 2026 · Last updated Jul 01, 2026 · Updated 4 times
Summary
This completed phase 2 trial tested whether oxytocin, given as a nasal spray or through an IV, can reduce pain from heat in healthy adults. Twenty-four participants rated their pain on a 0-10 scale after skin heating. The study also looked at whether age, weight, or sex affect how well oxytocin works.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- oxytocin
- What this could lead to
- If it works, this could point toward a new way to manage acute pain using oxytocin.
- What could go wrong
- This is a small, early-phase trial in healthy volunteers, not patients with chronic pain. The pain is lab-induced, so results may not apply to real-world pain conditions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAIN, ACUTE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Atrium Health Wake Forest Baptist
Winston-Salem, North Carolina, 27157, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a VR headset calm nerves before surgery?
- Can we predict chronic pain after breast cancer surgery?
- Virtual worlds may dull the sting of burn care for children
- Can a simple nerve block replace opioids after heart device surgery?
- Can a 5-Minute mindfulness text ease pain after joint replacement?
- Simple tricks to take the ouch out of blood tests